WebSigurdur (Siggi) Olafsson has been President, Chief Executive Officer and a director since June 2024. Mr. Olafsson has almost 30 years of diverse pharmaceutical experience across branded and generic drugs. Before joining Mallinckrodt, Mr. Olafsson served as CEO of Hikma Pharmaceuticals. WebApr 11, 2024 · -- Hikma Pharmaceuticals on Wednesday said it appointed Riad Mishlawi as the group's new chief executive officer, with effect Sept. 1. Mishlawi currently serves as the president of Hikma's... April 12, 2024
Leadership Hikma
WebHikma launches Icosapent Ethyl Capsules, 0.5g, in the US Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2024 financial results Notice of Annual … WebMr. Olafsson has almost 30 years of diverse pharmaceutical experience across branded and generic drugs. Before joining Mallinckrodt, Mr. Olafsson served as CEO of Hikma Pharmaceuticals. Prior to Hikma, Mr. Olafsson served as President and Chief Executive Officer of the Global Generic Medicines Group of Teva Pharmaceuticals. chilli plant for sale
Hikma Pharma names Mishlawi as next CEO - ET HealthWorld
WebMar 10, 2024 · Executive Summary. Hikma CEO Siggi Olafsson has outlined the potential future opportunity that the firm sees in the US biosimilars market, in the second part of an exclusive interview with Generics Bulletin. Source: Shutterstock Hikma could be a “great partner” on US biosimilars, Olafsson believes. Recent developments in US biosimilars … WebSep 27, 2024 · Hikma Pharmaceuticals CEO Siggi Olafsson said: “This acquisition provides Hikma with an attractive opportunity to further strengthen our US injectables business by adding an attractive and profitable portfolio of marketed products and an exciting pipeline of future opportunities. WebSep 14, 2024 · Our data indicates that Hikma Pharmaceuticals PLC has a market capitalization of UK£6.2b, and total annual CEO compensation was reported as US$4.1m … chillipop kids clothes